Stentys SA (STNT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stentys SA (STNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6457
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus release stent and stentys AC thromboaspiration catheter. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

Stentys SA (STNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stentys SA, Medical Equipment, Deal Details 10
Partnerships 10
Stentys Enters into Distribution Agreement with Micell for MiStent SES 10
Equity Offering 11
Stentys Raises USD14.6 Million in Rights Offering of Shares 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 12
Stentys Announced Private Placement Of Shares 14
Stentys Completes Rights Issue Of Shares For US$47.3 Million 15
Stentys Completes Private Placement Of Shares For US$11 Million 16
Acquisition 17
Stentys Acquire Minvasys for USD9.2 Million 17
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18
Stentys SA – Key Competitors 19
Stentys SA – Key Employees 20
Stentys SA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Oct 11, 2018: STENTYS: Financial Information for the Third Quarter of 2018 22
Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 23
Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 24
Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 25
Oct 02, 2017: STENTYS: 2017 half-year results 26
Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 27
Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 28
Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at €7.3 Million 29
Corporate Communications 30
Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 30
Product News 31
May 24, 2017: STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Stentys SA, Medical Equipment, Key Facts, 2017 2
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Deals By Market, 2012 to YTD 2018 8
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stentys Enters into Distribution Agreement with Micell for MiStent SES 10
Stentys Raises USD14.6 Million in Rights Offering of Shares 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 12
Stentys Announced Private Placement Of Shares 14
Stentys Completes Rights Issue Of Shares For US$47.3 Million 15
Stentys Completes Private Placement Of Shares For US$11 Million 16
Stentys Acquire Minvasys for USD9.2 Million 17
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18
Stentys SA, Key Competitors 19
Stentys SA, Key Employees 20
Stentys SA, Subsidiaries 21

List of Figures
Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stentys SA (STNT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Resonance Health Ltd (RHT):企業の財務・戦略的SWOT分析
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • S.C. Hidroelectrica SA:企業の戦略的SWOT分析
    S.C. Hidroelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Blackline Safety Corp. (BLN):企業の財務・戦略的SWOT分析
    Blackline Safety Corp. (BLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dexcel PT Israel Ltd:企業の戦略的SWOT分析
    Dexcel PT Israel Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Rice Energy Inc.:企業のM&A・事業提携・投資動向
    Rice Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rice Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SEACOR Holdings Inc.:企業の戦略・SWOT・財務分析
    SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Forestar Group Inc:企業の戦略・SWOT・財務分析
    Forestar Group Inc - Strategy, SWOT and Corporate Finance Report Summary Forestar Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • FRESHNESS, CO., LTD:企業の戦略・SWOT・財務情報
    FRESHNESS, CO., LTD - Strategy, SWOT and Corporate Finance Report Summary FRESHNESS, CO., LTD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • University of Michigan:企業のM&A・事業提携・投資動向
    University of Michigan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Michigan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Houston Methodist Hospital:企業の戦略的SWOT分析
    Houston Methodist Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Luxair S.A.:企業の戦略・SWOT・財務情報
    Luxair S.A. - Strategy, SWOT and Corporate Finance Report Summary Luxair S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Oracle Financial Services Software Limited (OFSS):企業の財務・戦略的SWOT分析
    Oracle Financial Services Software Limited (OFSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Nan Ya Plastics Corp (1303):企業の財務・戦略的SWOT分析
    Nan Ya Plastics Corp (1303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Korea East-West Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Sutter Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia Biosciences) is an agricultural and clean technology company that develops and commercializes agricultural products. The company's products exhibit traits include drought tolerance, stacked traits, herbicide tolerance, water use efficiency, nitrogen use effic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆